nodes	percent_of_prediction	percent_of_DWPC	metapath
Tinidazole—CYP3A4—Ifosfamide—testicular cancer	0.112	0.428	CbGbCtD
Tinidazole—CYP3A4—Vinblastine—testicular cancer	0.0594	0.227	CbGbCtD
Tinidazole—CYP3A4—Etoposide—testicular cancer	0.0535	0.205	CbGbCtD
Tinidazole—CYP3A4—Doxorubicin—testicular cancer	0.0365	0.14	CbGbCtD
Tinidazole—Skin disorder—Cisplatin—testicular cancer	0.00142	0.00193	CcSEcCtD
Tinidazole—Hyperhidrosis—Cisplatin—testicular cancer	0.00142	0.00192	CcSEcCtD
Tinidazole—Pruritus—Bleomycin—testicular cancer	0.00141	0.0019	CcSEcCtD
Tinidazole—Feeling abnormal—Ifosfamide—testicular cancer	0.0014	0.0019	CcSEcCtD
Tinidazole—Nausea—Vinblastine—testicular cancer	0.0014	0.00189	CcSEcCtD
Tinidazole—Anorexia—Cisplatin—testicular cancer	0.0014	0.00189	CcSEcCtD
Tinidazole—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.00139	0.00188	CcSEcCtD
Tinidazole—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00139	0.00188	CcSEcCtD
Tinidazole—Discomfort—Etoposide—testicular cancer	0.00138	0.00187	CcSEcCtD
Tinidazole—Aspartate aminotransferase increased—Epirubicin—testicular cancer	0.00138	0.00187	CcSEcCtD
Tinidazole—Hypersensitivity—Dactinomycin—testicular cancer	0.00137	0.00185	CcSEcCtD
Tinidazole—Confusional state—Etoposide—testicular cancer	0.00135	0.00183	CcSEcCtD
Tinidazole—Urticaria—Ifosfamide—testicular cancer	0.00135	0.00183	CcSEcCtD
Tinidazole—Abdominal pain—Ifosfamide—testicular cancer	0.00134	0.00182	CcSEcCtD
Tinidazole—Body temperature increased—Ifosfamide—testicular cancer	0.00134	0.00182	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.00133	0.00181	CcSEcCtD
Tinidazole—Ataxia—Doxorubicin—testicular cancer	0.00133	0.0018	CcSEcCtD
Tinidazole—Asthenia—Dactinomycin—testicular cancer	0.00133	0.0018	CcSEcCtD
Tinidazole—Dysuria—Methotrexate—testicular cancer	0.00132	0.00179	CcSEcCtD
Tinidazole—Neutropenia—Methotrexate—testicular cancer	0.00132	0.00179	CcSEcCtD
Tinidazole—Paraesthesia—Cisplatin—testicular cancer	0.00132	0.00178	CcSEcCtD
Tinidazole—Thrombocytopenia—Etoposide—testicular cancer	0.00131	0.00178	CcSEcCtD
Tinidazole—Dyspnoea—Cisplatin—testicular cancer	0.00131	0.00177	CcSEcCtD
Tinidazole—Skin disorder—Etoposide—testicular cancer	0.0013	0.00176	CcSEcCtD
Tinidazole—Hyperhidrosis—Etoposide—testicular cancer	0.0013	0.00176	CcSEcCtD
Tinidazole—Anorexia—Etoposide—testicular cancer	0.00128	0.00173	CcSEcCtD
Tinidazole—Aspartate aminotransferase increased—Doxorubicin—testicular cancer	0.00128	0.00173	CcSEcCtD
Tinidazole—Decreased appetite—Cisplatin—testicular cancer	0.00127	0.00172	CcSEcCtD
Tinidazole—Diarrhoea—Dactinomycin—testicular cancer	0.00127	0.00172	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00126	0.00171	CcSEcCtD
Tinidazole—Vomiting—Bleomycin—testicular cancer	0.00126	0.00171	CcSEcCtD
Tinidazole—Drowsiness—Methotrexate—testicular cancer	0.00126	0.00171	CcSEcCtD
Tinidazole—Rash—Bleomycin—testicular cancer	0.00125	0.0017	CcSEcCtD
Tinidazole—Dermatitis—Bleomycin—testicular cancer	0.00125	0.0017	CcSEcCtD
Tinidazole—Hypersensitivity—Ifosfamide—testicular cancer	0.00125	0.00169	CcSEcCtD
Tinidazole—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.00125	0.00169	CcSEcCtD
Tinidazole—Dysuria—Epirubicin—testicular cancer	0.00124	0.00167	CcSEcCtD
Tinidazole—Neutropenia—Epirubicin—testicular cancer	0.00124	0.00167	CcSEcCtD
Tinidazole—Stomatitis—Methotrexate—testicular cancer	0.00123	0.00166	CcSEcCtD
Tinidazole—Asthenia—Ifosfamide—testicular cancer	0.00122	0.00165	CcSEcCtD
Tinidazole—Sweating—Methotrexate—testicular cancer	0.00121	0.00164	CcSEcCtD
Tinidazole—Feeling abnormal—Cisplatin—testicular cancer	0.00121	0.00163	CcSEcCtD
Tinidazole—Paraesthesia—Etoposide—testicular cancer	0.00121	0.00163	CcSEcCtD
Tinidazole—Pruritus—Ifosfamide—testicular cancer	0.0012	0.00163	CcSEcCtD
Tinidazole—Dyspnoea—Etoposide—testicular cancer	0.0012	0.00162	CcSEcCtD
Tinidazole—Somnolence—Etoposide—testicular cancer	0.00119	0.00162	CcSEcCtD
Tinidazole—Nausea—Bleomycin—testicular cancer	0.00118	0.0016	CcSEcCtD
Tinidazole—Drowsiness—Epirubicin—testicular cancer	0.00118	0.0016	CcSEcCtD
Tinidazole—Vomiting—Dactinomycin—testicular cancer	0.00118	0.0016	CcSEcCtD
Tinidazole—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.00117	0.00158	CcSEcCtD
Tinidazole—Rash—Dactinomycin—testicular cancer	0.00117	0.00158	CcSEcCtD
Tinidazole—Decreased appetite—Etoposide—testicular cancer	0.00117	0.00158	CcSEcCtD
Tinidazole—Diarrhoea—Ifosfamide—testicular cancer	0.00116	0.00157	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Etoposide—testicular cancer	0.00116	0.00157	CcSEcCtD
Tinidazole—Body temperature increased—Cisplatin—testicular cancer	0.00116	0.00157	CcSEcCtD
Tinidazole—Fatigue—Etoposide—testicular cancer	0.00116	0.00157	CcSEcCtD
Tinidazole—Neuropathy peripheral—Epirubicin—testicular cancer	0.00116	0.00157	CcSEcCtD
Tinidazole—Stomatitis—Epirubicin—testicular cancer	0.00115	0.00156	CcSEcCtD
Tinidazole—Constipation—Etoposide—testicular cancer	0.00115	0.00155	CcSEcCtD
Tinidazole—Urinary tract infection—Epirubicin—testicular cancer	0.00115	0.00155	CcSEcCtD
Tinidazole—Dysuria—Doxorubicin—testicular cancer	0.00114	0.00155	CcSEcCtD
Tinidazole—Neutropenia—Doxorubicin—testicular cancer	0.00114	0.00155	CcSEcCtD
Tinidazole—Sweating—Epirubicin—testicular cancer	0.00113	0.00153	CcSEcCtD
Tinidazole—Dizziness—Ifosfamide—testicular cancer	0.00112	0.00152	CcSEcCtD
Tinidazole—Pharyngitis—Methotrexate—testicular cancer	0.00112	0.00152	CcSEcCtD
Tinidazole—Urinary tract disorder—Methotrexate—testicular cancer	0.00112	0.00151	CcSEcCtD
Tinidazole—Urethral disorder—Methotrexate—testicular cancer	0.00111	0.0015	CcSEcCtD
Tinidazole—Feeling abnormal—Etoposide—testicular cancer	0.00111	0.0015	CcSEcCtD
Tinidazole—Nausea—Dactinomycin—testicular cancer	0.0011	0.00149	CcSEcCtD
Tinidazole—Gastrointestinal pain—Etoposide—testicular cancer	0.0011	0.00149	CcSEcCtD
Tinidazole—Drowsiness—Doxorubicin—testicular cancer	0.00109	0.00148	CcSEcCtD
Tinidazole—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.00108	0.00146	CcSEcCtD
Tinidazole—Vomiting—Ifosfamide—testicular cancer	0.00108	0.00146	CcSEcCtD
Tinidazole—Hypersensitivity—Cisplatin—testicular cancer	0.00108	0.00146	CcSEcCtD
Tinidazole—Rash—Ifosfamide—testicular cancer	0.00107	0.00145	CcSEcCtD
Tinidazole—Dermatitis—Ifosfamide—testicular cancer	0.00107	0.00145	CcSEcCtD
Tinidazole—Erythema multiforme—Methotrexate—testicular cancer	0.00107	0.00145	CcSEcCtD
Tinidazole—Neuropathy peripheral—Doxorubicin—testicular cancer	0.00107	0.00145	CcSEcCtD
Tinidazole—Urticaria—Etoposide—testicular cancer	0.00107	0.00144	CcSEcCtD
Tinidazole—Stomatitis—Doxorubicin—testicular cancer	0.00106	0.00144	CcSEcCtD
Tinidazole—Abdominal pain—Etoposide—testicular cancer	0.00106	0.00144	CcSEcCtD
Tinidazole—Body temperature increased—Etoposide—testicular cancer	0.00106	0.00144	CcSEcCtD
Tinidazole—Urinary tract infection—Doxorubicin—testicular cancer	0.00106	0.00144	CcSEcCtD
Tinidazole—Hypoaesthesia—Epirubicin—testicular cancer	0.00105	0.00143	CcSEcCtD
Tinidazole—Asthenia—Cisplatin—testicular cancer	0.00105	0.00142	CcSEcCtD
Tinidazole—Pharyngitis—Epirubicin—testicular cancer	0.00105	0.00142	CcSEcCtD
Tinidazole—Sweating—Doxorubicin—testicular cancer	0.00105	0.00142	CcSEcCtD
Tinidazole—Urinary tract disorder—Epirubicin—testicular cancer	0.00105	0.00142	CcSEcCtD
Tinidazole—Urethral disorder—Epirubicin—testicular cancer	0.00104	0.00141	CcSEcCtD
Tinidazole—Angiopathy—Methotrexate—testicular cancer	0.00103	0.00139	CcSEcCtD
Tinidazole—Immune system disorder—Methotrexate—testicular cancer	0.00102	0.00138	CcSEcCtD
Tinidazole—Nausea—Ifosfamide—testicular cancer	0.00101	0.00137	CcSEcCtD
Tinidazole—Diarrhoea—Cisplatin—testicular cancer	0.001	0.00136	CcSEcCtD
Tinidazole—Erythema multiforme—Epirubicin—testicular cancer	0.001	0.00136	CcSEcCtD
Tinidazole—Hypersensitivity—Etoposide—testicular cancer	0.000989	0.00134	CcSEcCtD
Tinidazole—Malnutrition—Methotrexate—testicular cancer	0.000985	0.00133	CcSEcCtD
Tinidazole—Flushing—Epirubicin—testicular cancer	0.000983	0.00133	CcSEcCtD
Tinidazole—Hypoaesthesia—Doxorubicin—testicular cancer	0.000975	0.00132	CcSEcCtD
Tinidazole—Pharyngitis—Doxorubicin—testicular cancer	0.000972	0.00132	CcSEcCtD
Tinidazole—Urinary tract disorder—Doxorubicin—testicular cancer	0.000968	0.00131	CcSEcCtD
Tinidazole—Dysgeusia—Methotrexate—testicular cancer	0.000965	0.00131	CcSEcCtD
Tinidazole—Asthenia—Etoposide—testicular cancer	0.000963	0.0013	CcSEcCtD
Tinidazole—Angiopathy—Epirubicin—testicular cancer	0.000961	0.0013	CcSEcCtD
Tinidazole—Urethral disorder—Doxorubicin—testicular cancer	0.00096	0.0013	CcSEcCtD
Tinidazole—Immune system disorder—Epirubicin—testicular cancer	0.000956	0.00129	CcSEcCtD
Tinidazole—Pruritus—Etoposide—testicular cancer	0.00095	0.00129	CcSEcCtD
Tinidazole—Vomiting—Cisplatin—testicular cancer	0.000931	0.00126	CcSEcCtD
Tinidazole—Erythema multiforme—Doxorubicin—testicular cancer	0.000926	0.00125	CcSEcCtD
Tinidazole—Rash—Cisplatin—testicular cancer	0.000924	0.00125	CcSEcCtD
Tinidazole—Dermatitis—Cisplatin—testicular cancer	0.000923	0.00125	CcSEcCtD
Tinidazole—Malnutrition—Epirubicin—testicular cancer	0.000922	0.00125	CcSEcCtD
Tinidazole—Diarrhoea—Etoposide—testicular cancer	0.000918	0.00124	CcSEcCtD
Tinidazole—Ill-defined disorder—Methotrexate—testicular cancer	0.000914	0.00124	CcSEcCtD
Tinidazole—Flushing—Doxorubicin—testicular cancer	0.000909	0.00123	CcSEcCtD
Tinidazole—Flatulence—Epirubicin—testicular cancer	0.000908	0.00123	CcSEcCtD
Tinidazole—Dysgeusia—Epirubicin—testicular cancer	0.000903	0.00122	CcSEcCtD
Tinidazole—Angiopathy—Doxorubicin—testicular cancer	0.000889	0.0012	CcSEcCtD
Tinidazole—Malaise—Methotrexate—testicular cancer	0.000888	0.0012	CcSEcCtD
Tinidazole—Dizziness—Etoposide—testicular cancer	0.000887	0.0012	CcSEcCtD
Tinidazole—Muscle spasms—Epirubicin—testicular cancer	0.000886	0.0012	CcSEcCtD
Tinidazole—Immune system disorder—Doxorubicin—testicular cancer	0.000885	0.0012	CcSEcCtD
Tinidazole—Vertigo—Methotrexate—testicular cancer	0.000885	0.0012	CcSEcCtD
Tinidazole—Leukopenia—Methotrexate—testicular cancer	0.000882	0.00119	CcSEcCtD
Tinidazole—Nausea—Cisplatin—testicular cancer	0.00087	0.00118	CcSEcCtD
Tinidazole—Ill-defined disorder—Epirubicin—testicular cancer	0.000855	0.00116	CcSEcCtD
Tinidazole—Convulsion—Methotrexate—testicular cancer	0.000853	0.00116	CcSEcCtD
Tinidazole—Vomiting—Etoposide—testicular cancer	0.000853	0.00116	CcSEcCtD
Tinidazole—Malnutrition—Doxorubicin—testicular cancer	0.000853	0.00115	CcSEcCtD
Tinidazole—Rash—Etoposide—testicular cancer	0.000846	0.00115	CcSEcCtD
Tinidazole—Dermatitis—Etoposide—testicular cancer	0.000845	0.00114	CcSEcCtD
Tinidazole—Headache—Etoposide—testicular cancer	0.000841	0.00114	CcSEcCtD
Tinidazole—Flatulence—Doxorubicin—testicular cancer	0.00084	0.00114	CcSEcCtD
Tinidazole—Myalgia—Methotrexate—testicular cancer	0.000839	0.00114	CcSEcCtD
Tinidazole—Arthralgia—Methotrexate—testicular cancer	0.000839	0.00114	CcSEcCtD
Tinidazole—Dysgeusia—Doxorubicin—testicular cancer	0.000835	0.00113	CcSEcCtD
Tinidazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000833	0.00113	CcSEcCtD
Tinidazole—Malaise—Epirubicin—testicular cancer	0.000831	0.00113	CcSEcCtD
Tinidazole—Discomfort—Methotrexate—testicular cancer	0.000829	0.00112	CcSEcCtD
Tinidazole—Vertigo—Epirubicin—testicular cancer	0.000828	0.00112	CcSEcCtD
Tinidazole—Leukopenia—Epirubicin—testicular cancer	0.000825	0.00112	CcSEcCtD
Tinidazole—Muscle spasms—Doxorubicin—testicular cancer	0.00082	0.00111	CcSEcCtD
Tinidazole—Palpitations—Epirubicin—testicular cancer	0.000815	0.0011	CcSEcCtD
Tinidazole—Confusional state—Methotrexate—testicular cancer	0.000811	0.0011	CcSEcCtD
Tinidazole—Convulsion—Epirubicin—testicular cancer	0.000799	0.00108	CcSEcCtD
Tinidazole—Nausea—Etoposide—testicular cancer	0.000797	0.00108	CcSEcCtD
Tinidazole—Ill-defined disorder—Doxorubicin—testicular cancer	0.000791	0.00107	CcSEcCtD
Tinidazole—Nervous system disorder—Methotrexate—testicular cancer	0.000788	0.00107	CcSEcCtD
Tinidazole—Thrombocytopenia—Methotrexate—testicular cancer	0.000787	0.00107	CcSEcCtD
Tinidazole—Myalgia—Epirubicin—testicular cancer	0.000785	0.00106	CcSEcCtD
Tinidazole—Arthralgia—Epirubicin—testicular cancer	0.000785	0.00106	CcSEcCtD
Tinidazole—Skin disorder—Methotrexate—testicular cancer	0.000781	0.00106	CcSEcCtD
Tinidazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000779	0.00105	CcSEcCtD
Tinidazole—Hyperhidrosis—Methotrexate—testicular cancer	0.000777	0.00105	CcSEcCtD
Tinidazole—Discomfort—Epirubicin—testicular cancer	0.000775	0.00105	CcSEcCtD
Tinidazole—Malaise—Doxorubicin—testicular cancer	0.000769	0.00104	CcSEcCtD
Tinidazole—Vertigo—Doxorubicin—testicular cancer	0.000766	0.00104	CcSEcCtD
Tinidazole—Anorexia—Methotrexate—testicular cancer	0.000766	0.00104	CcSEcCtD
Tinidazole—Leukopenia—Doxorubicin—testicular cancer	0.000763	0.00103	CcSEcCtD
Tinidazole—Confusional state—Epirubicin—testicular cancer	0.000759	0.00103	CcSEcCtD
Tinidazole—Palpitations—Doxorubicin—testicular cancer	0.000754	0.00102	CcSEcCtD
Tinidazole—Convulsion—Doxorubicin—testicular cancer	0.000739	0.001	CcSEcCtD
Tinidazole—Nervous system disorder—Epirubicin—testicular cancer	0.000738	0.000999	CcSEcCtD
Tinidazole—Thrombocytopenia—Epirubicin—testicular cancer	0.000737	0.000997	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000732	0.000991	CcSEcCtD
Tinidazole—Skin disorder—Epirubicin—testicular cancer	0.000731	0.000989	CcSEcCtD
Tinidazole—Hyperhidrosis—Epirubicin—testicular cancer	0.000727	0.000984	CcSEcCtD
Tinidazole—Insomnia—Methotrexate—testicular cancer	0.000727	0.000984	CcSEcCtD
Tinidazole—Myalgia—Doxorubicin—testicular cancer	0.000726	0.000983	CcSEcCtD
Tinidazole—Arthralgia—Doxorubicin—testicular cancer	0.000726	0.000983	CcSEcCtD
Tinidazole—Paraesthesia—Methotrexate—testicular cancer	0.000722	0.000977	CcSEcCtD
Tinidazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000721	0.000976	CcSEcCtD
Tinidazole—Discomfort—Doxorubicin—testicular cancer	0.000717	0.000971	CcSEcCtD
Tinidazole—Anorexia—Epirubicin—testicular cancer	0.000717	0.000971	CcSEcCtD
Tinidazole—Dyspnoea—Methotrexate—testicular cancer	0.000717	0.00097	CcSEcCtD
Tinidazole—Somnolence—Methotrexate—testicular cancer	0.000715	0.000967	CcSEcCtD
Tinidazole—Dyspepsia—Methotrexate—testicular cancer	0.000708	0.000958	CcSEcCtD
Tinidazole—Confusional state—Doxorubicin—testicular cancer	0.000702	0.00095	CcSEcCtD
Tinidazole—Decreased appetite—Methotrexate—testicular cancer	0.000699	0.000946	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000694	0.000939	CcSEcCtD
Tinidazole—Fatigue—Methotrexate—testicular cancer	0.000693	0.000938	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000685	0.000928	CcSEcCtD
Tinidazole—Nervous system disorder—Doxorubicin—testicular cancer	0.000683	0.000924	CcSEcCtD
Tinidazole—Thrombocytopenia—Doxorubicin—testicular cancer	0.000682	0.000923	CcSEcCtD
Tinidazole—Insomnia—Epirubicin—testicular cancer	0.00068	0.000921	CcSEcCtD
Tinidazole—Skin disorder—Doxorubicin—testicular cancer	0.000676	0.000915	CcSEcCtD
Tinidazole—Paraesthesia—Epirubicin—testicular cancer	0.000676	0.000914	CcSEcCtD
Tinidazole—Hyperhidrosis—Doxorubicin—testicular cancer	0.000673	0.000911	CcSEcCtD
Tinidazole—Dyspnoea—Epirubicin—testicular cancer	0.000671	0.000908	CcSEcCtD
Tinidazole—Somnolence—Epirubicin—testicular cancer	0.000669	0.000905	CcSEcCtD
Tinidazole—Anorexia—Doxorubicin—testicular cancer	0.000664	0.000898	CcSEcCtD
Tinidazole—Feeling abnormal—Methotrexate—testicular cancer	0.000662	0.000897	CcSEcCtD
Tinidazole—Dyspepsia—Epirubicin—testicular cancer	0.000662	0.000896	CcSEcCtD
Tinidazole—Gastrointestinal pain—Methotrexate—testicular cancer	0.000657	0.00089	CcSEcCtD
Tinidazole—Decreased appetite—Epirubicin—testicular cancer	0.000654	0.000885	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000649	0.000879	CcSEcCtD
Tinidazole—Fatigue—Epirubicin—testicular cancer	0.000649	0.000878	CcSEcCtD
Tinidazole—Constipation—Epirubicin—testicular cancer	0.000643	0.000871	CcSEcCtD
Tinidazole—Urticaria—Methotrexate—testicular cancer	0.000639	0.000864	CcSEcCtD
Tinidazole—Body temperature increased—Methotrexate—testicular cancer	0.000635	0.00086	CcSEcCtD
Tinidazole—Abdominal pain—Methotrexate—testicular cancer	0.000635	0.00086	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000634	0.000858	CcSEcCtD
Tinidazole—Insomnia—Doxorubicin—testicular cancer	0.00063	0.000852	CcSEcCtD
Tinidazole—Paraesthesia—Doxorubicin—testicular cancer	0.000625	0.000846	CcSEcCtD
Tinidazole—Dyspnoea—Doxorubicin—testicular cancer	0.000621	0.00084	CcSEcCtD
Tinidazole—Feeling abnormal—Epirubicin—testicular cancer	0.00062	0.000839	CcSEcCtD
Tinidazole—Somnolence—Doxorubicin—testicular cancer	0.000619	0.000838	CcSEcCtD
Tinidazole—Gastrointestinal pain—Epirubicin—testicular cancer	0.000615	0.000833	CcSEcCtD
Tinidazole—Dyspepsia—Doxorubicin—testicular cancer	0.000613	0.000829	CcSEcCtD
Tinidazole—Decreased appetite—Doxorubicin—testicular cancer	0.000605	0.000819	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000601	0.000813	CcSEcCtD
Tinidazole—Fatigue—Doxorubicin—testicular cancer	0.0006	0.000812	CcSEcCtD
Tinidazole—Urticaria—Epirubicin—testicular cancer	0.000598	0.000809	CcSEcCtD
Tinidazole—Constipation—Doxorubicin—testicular cancer	0.000595	0.000806	CcSEcCtD
Tinidazole—Abdominal pain—Epirubicin—testicular cancer	0.000595	0.000805	CcSEcCtD
Tinidazole—Body temperature increased—Epirubicin—testicular cancer	0.000595	0.000805	CcSEcCtD
Tinidazole—Hypersensitivity—Methotrexate—testicular cancer	0.000592	0.000802	CcSEcCtD
Tinidazole—Asthenia—Methotrexate—testicular cancer	0.000577	0.000781	CcSEcCtD
Tinidazole—Feeling abnormal—Doxorubicin—testicular cancer	0.000574	0.000776	CcSEcCtD
Tinidazole—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000569	0.00077	CcSEcCtD
Tinidazole—Pruritus—Methotrexate—testicular cancer	0.000569	0.00077	CcSEcCtD
Tinidazole—Hypersensitivity—Epirubicin—testicular cancer	0.000554	0.00075	CcSEcCtD
Tinidazole—Urticaria—Doxorubicin—testicular cancer	0.000553	0.000749	CcSEcCtD
Tinidazole—Abdominal pain—Doxorubicin—testicular cancer	0.00055	0.000745	CcSEcCtD
Tinidazole—Body temperature increased—Doxorubicin—testicular cancer	0.00055	0.000745	CcSEcCtD
Tinidazole—Diarrhoea—Methotrexate—testicular cancer	0.00055	0.000745	CcSEcCtD
Tinidazole—Asthenia—Epirubicin—testicular cancer	0.00054	0.000731	CcSEcCtD
Tinidazole—Pruritus—Epirubicin—testicular cancer	0.000532	0.00072	CcSEcCtD
Tinidazole—Dizziness—Methotrexate—testicular cancer	0.000532	0.00072	CcSEcCtD
Tinidazole—Diarrhoea—Epirubicin—testicular cancer	0.000515	0.000697	CcSEcCtD
Tinidazole—Hypersensitivity—Doxorubicin—testicular cancer	0.000513	0.000694	CcSEcCtD
Tinidazole—Vomiting—Methotrexate—testicular cancer	0.000511	0.000692	CcSEcCtD
Tinidazole—Rash—Methotrexate—testicular cancer	0.000507	0.000686	CcSEcCtD
Tinidazole—Dermatitis—Methotrexate—testicular cancer	0.000506	0.000685	CcSEcCtD
Tinidazole—Headache—Methotrexate—testicular cancer	0.000504	0.000682	CcSEcCtD
Tinidazole—Asthenia—Doxorubicin—testicular cancer	0.000499	0.000676	CcSEcCtD
Tinidazole—Dizziness—Epirubicin—testicular cancer	0.000497	0.000673	CcSEcCtD
Tinidazole—Pruritus—Doxorubicin—testicular cancer	0.000492	0.000667	CcSEcCtD
Tinidazole—Vomiting—Epirubicin—testicular cancer	0.000478	0.000647	CcSEcCtD
Tinidazole—Nausea—Methotrexate—testicular cancer	0.000477	0.000646	CcSEcCtD
Tinidazole—Diarrhoea—Doxorubicin—testicular cancer	0.000476	0.000645	CcSEcCtD
Tinidazole—Rash—Epirubicin—testicular cancer	0.000474	0.000642	CcSEcCtD
Tinidazole—Dermatitis—Epirubicin—testicular cancer	0.000474	0.000641	CcSEcCtD
Tinidazole—Headache—Epirubicin—testicular cancer	0.000471	0.000638	CcSEcCtD
Tinidazole—Dizziness—Doxorubicin—testicular cancer	0.00046	0.000623	CcSEcCtD
Tinidazole—Nausea—Epirubicin—testicular cancer	0.000447	0.000605	CcSEcCtD
Tinidazole—Vomiting—Doxorubicin—testicular cancer	0.000443	0.000599	CcSEcCtD
Tinidazole—Rash—Doxorubicin—testicular cancer	0.000439	0.000594	CcSEcCtD
Tinidazole—Dermatitis—Doxorubicin—testicular cancer	0.000438	0.000594	CcSEcCtD
Tinidazole—Headache—Doxorubicin—testicular cancer	0.000436	0.00059	CcSEcCtD
Tinidazole—Nausea—Doxorubicin—testicular cancer	0.000413	0.00056	CcSEcCtD
